Abstract
In this study, the ability of six limonoids from Trichilia prieuriana (Meliaceae) to activate the liver X receptor (LXR) was assessed. One of these limonoids, flindissone, was shown to activate LXR by reporter-gene assays. Flindissone is a ring-intact limonoid, structurally similar to sterol-like LXR ligands. In endogenous cellular settings, flindissone showed an activity profile that is characteristic of LXR agonists. It induced cholesterol efflux in THP-1 macrophages by increasing the cholesterol transporter ABCA1 and ABCG1 gene expression. In HepG2 cells, flindissone induced the expression of IDOL, an LXR-target gene that is associated with the downregulation of the LDL receptor. However, unlike synthetic and similarly to sterol-based LXR agonists, flindissone did not induce the expression of the SREBP1c gene, a major transcription factor regulating de novo lipogenesis. Additionally, flindissone also appeared to be able to inhibit post-translational activation of SREBP1c. The results presented here reveal a natural product as a new LXR agonist and point to an additional property of T. prieuriana and other plant extracts containing flindissone.
| Original language | English |
|---|---|
| Pages (from-to) | 1901-1909 |
| Number of pages | 9 |
| Journal | Journal of Natural Products |
| Volume | 86 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 25 Aug 2023 |
Funding
We gratefully acknowledge the funding provided by the Austrian Science Fund (FWF): Project number P35241–B to Verena M. Dirsch and by the Ernst Mach Grant (OEAD) awarded to Borris R. Tietcheu Galani: Reference number ICM-2020-00069. We are very grateful to OPCW (Organisation for the Prohibition of Chemical Weapons) for the postdoctoral fellowship of Armelle T. Tsamo.
Austrian Fields of Science 2012
- 301206 Pharmacology
- 104002 Analytical chemistry
- 301209 Pharmacy
- 301303 Medical biochemistry